Legacy Edge Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Legacy Edge Advisors's AMGN Position: Q3 2026 in Review
Legacy Edge Advisors reduced its Amgen (AMGN) stake by 3.1% in Q3 2026, selling an estimated $17.5K and leaving 1,390 shares worth $586K. The position accounts for 0.05% of the portfolio, ranked #135.
Legacy Edge Advisors first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Legacy Edge Advisors held 1,390 shares of Amgen worth $586K as of Q3 2026.
- Legacy Edge Advisors sold 44 Amgen shares in Q3 2026, an estimated $17.5K.
- Amgen made up 0.05% of Legacy Edge Advisors's portfolio in Q3 2026, its #135 holding.
- Legacy Edge Advisors first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
- 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Legacy Edge Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.